IP-6 infringement
This article was originally published in The Tan Sheet
Executive Summary
BNG Enterprises and Lifesource Naturals settle infringement lawsuits filed by supplement maker Enzymatic Therapy and Abulkalam Shamsuddin, MD/PhD. BNG and Lifesource are enjoined from selling products combining inositol and inositol hexaphosphate (IP-6) for the remaining term of the '833 patent, according to consent orders entered in Baltimore, Md. federal court. Enzymatic's Cell Forte with IP-6 & Inositol is covered by the '833 patent, which it licenses from Shamsuddin